Kira Bona, MD, MPH
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Associate Professor of Pediatrics, Harvard Medical School
Image
Kira Bona, MD, MPH
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Associate Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Graduate School
Harvard T.H. Chan School of Public Health
Boston
MA
Medical School
Yale University School of Medicine
New Haven
CT
Residency
Boston Combined Residency Program (BCRP)
Boston
MA
Fellowship
Pediatric Hematology-Oncology
Boston Children's Hospital / Dana-Farber Cancer Institute
Boston
MA
Certifications
American Board of Pediatrics (General)
Professional History
Dr. Kira Bona received her MD from the Yale University School of Medicine and her MPH from the Harvard T.H. Chan School of Public Health with a focus on clinical effectiveness. She completed her pediatrics residency in the Boston Combined Residency Program (BCRP) at Boston Children’s Hospital and Boston Medical Center and her pediatric hematology/oncology subspecialty fellowship training at Dana-Farber Cancer Institute/Boston Children’s Hospital. She joined the faculty at Dana-Farber/Boston Children’s as a pediatric oncologist in 2012. In addition to her role in the treatment of children with leukemia and lymphoma, Dr. Bona is a physician-scientist with research focused on identifying poverty-associated outcome disparities in childhood cancer and developing interventions to ameliorate these disparities. Dr. Bona has been the recipient of several past awards and honors including a Young Investigator Award from the American Society of Clinical Oncology, a St. Baldrick’s Fellow Award, a Junior Faculty Career Development Award from the National Palliative Care Research Center, a Charles H. Hood Child Health Research Grant, and an NCI K07 Mentored Career Development Award.
Publications
Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia. View Abstract
Baseline Neurocognitive Functioning Among Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana Farber Cancer Institute ALL Consortium Study 16-001. View Abstract
Baseline Characteristics of Parents Enrolled in Children's Oncology Group Study ACCL20N1CD: Financial Toxicity During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States. View Abstract
Racial and Ethnic Survival Disparities Among Children With High-Risk Neuroblastoma: A Children's Oncology Group Report. View Abstract
Historical redlining and survival among children, adolescents, and young adults with cancer diagnosed between 2000-2019 in Seattle and Tacoma, Washington. View Abstract
Development and refinement of the Cardiovascular Health Equity through Food (CHEF) intervention for childhood cancer survivors. View Abstract
Targeting hardship: poverty as a modifiable risk factor in childhood leukemia and lymphoma treatment. View Abstract
Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children's Oncology Group report. View Abstract
Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumoronly versus paired tumor-normal sequencing. View Abstract
Impact of Genetic Ancestry on T-cell Acute Lymphoblastic Leukemia Outcomes. View Abstract
Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohort. View Abstract
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials. View Abstract
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. View Abstract
Household material hardship and distress among parents of children with advanced cancer: A report from the PediQUEST Response trial. View Abstract
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group. View Abstract
Providing Groceries and Transportation to Poverty-Exposed Pediatric Oncology Families: The PediCARE Pilot Randomized Clinical Trial. View Abstract
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research. View Abstract
Inequitable Poverty Exposures: A Subspecialty Opportunity to Address Disparities. View Abstract
Prescription for Cash? Cash Support to Low-Income Families in Maternal and Pediatric Health Care Settings. View Abstract
Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia. View Abstract
Children's Oncology Group's 2023 blueprint for research: Diversity and health disparities. View Abstract
Gaps in Parental Understanding of Sleep Disturbances During Maintenance Therapy for Pediatric Acute Lymphoblastic Leukemia. View Abstract
"It's a lot of things": Household material hardship among Black and Hispanic parents of children with cancer. View Abstract
Association of unmet basic resource needs with frailty and quality of life among older adults with cancer-Results from the CARE registry. View Abstract
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy. View Abstract
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials. View Abstract
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease. View Abstract
Addressing Social Determinants of Health: Now Is the Time. View Abstract
"The simple life experiences that every other human gets": Desire for normalcy among adolescents and young adults with advanced cancer. View Abstract
Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium. View Abstract
Feasibility of oncology clinical trial-embedded evaluation of social determinants of health. View Abstract
Rationale and design of Children's Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States. View Abstract
A Structural Racism Framework to Guide Health Equity Interventions in Pediatric Oncology. View Abstract
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia. View Abstract
Missing Voices: Lessons Learned from Nonparticipating Caregivers in Palliative Care Research. View Abstract
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia. View Abstract
Disparities in pediatric psychosocial oncology utilization. View Abstract
Pediatric Palliative Care Parents' Distress, Financial Difficulty, and Child Symptoms. View Abstract
Naming the Problem: A Structural Racism Framework to Examine Disparities in Palliative Care. View Abstract
Race, ethnicity, and goal-concordance of end-of-life palliative care in pediatric oncology. View Abstract
PediCARE: Development of a poverty-targeted intervention for pediatric cancer. View Abstract
Disparities in Pediatric Oncology: The 21st Century Opportunity to Improve Outcomes for Children and Adolescents With Cancer. View Abstract
Socioeconomic disparities in survival after high-risk neuroblastoma treatment with modern therapy. View Abstract
Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology. View Abstract
Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma. View Abstract
Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis. View Abstract
Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children's Oncology Group Trials. View Abstract
Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children's Oncology Group Trials. View Abstract
Off-label prescribing of targeted anticancer therapy at a large pediatric cancer center. View Abstract
Examining key sociodemographic characteristics of adolescents and young adults with cancer: A post hoc analysis of the Promoting Resilience in Stress Management randomized clinical trial. View Abstract
Distress and resilience among adolescents and young adults with cancer and their mothers: An exploratory analysis. View Abstract
Pediatric Palliative Care in the Multicultural Context: Findings From a Workshop Conference. View Abstract
The relationship between household income and patient-reported symptom distress and quality of life in children with advanced cancer: A report from the PediQUEST study. View Abstract
What we did not learn from an exploratory analysis of economic hardship in newly diagnosed adolescents and young adults with cancer. View Abstract
Feasibility of systematic poverty screening in a pediatric oncology referral center. View Abstract
An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. View Abstract
Hope, distress, and later quality of life among adolescent and young adults with cancer. View Abstract
Disparities in Pediatric Palliative Care: An Opportunity to Strive for Equity. View Abstract
Household material hardship in families of children post-chemotherapy. View Abstract
The Benefits and Burdens of Cancer: A Prospective Longitudinal Cohort Study of Adolescents and Young Adults. View Abstract
Intimacy, Substance Use, and Communication Needs During Cancer Therapy: A Report From the "Resilience in Adolescents and Young Adults" Study. View Abstract
The benefits and burdens of cancer: A prospective, longitudinal cohort study of adolescents and young adults. View Abstract
Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation. View Abstract
The Power of Personal Narrative: A Reply to "The Reality of Relapse: Impact of Cancer Relapse on Survivorship Interventions and Patient-Reported Outcomes Data". View Abstract
Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010). View Abstract
Adolescent and Young Adult Patient Engagement and Participation in Survey-Based Research: A Report From the "Resilience in Adolescents and Young Adults With Cancer" Study. View Abstract
Assessment of Financial Burden as a Standard of Care in Pediatric Oncology. View Abstract
Trajectory of Material Hardship and Income Poverty in Families of Children Undergoing Chemotherapy: A Prospective Cohort Study. View Abstract
Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families. View Abstract
Economic impact of advanced pediatric cancer on families. View Abstract
Massachusetts' Pediatric Palliative Care Network: successful implementation of a novel state-funded pediatric palliative care program. View Abstract
Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer. View Abstract
Diagnosis and management of adults with pharyngitis. A cost-effectiveness analysis. View Abstract